Table 2

Meta-analysis of the statistical performance of the predictive variables for the diagnosis of group A streptococcal pharyngitis in children

VariablesReferencesPop (n)Se (95% CI)Sp (95% CI)PPV (95% CI)NPV (95% CI)LR+ (95% CI)LR− (95% CI)OR (95% CI)
Positive symptoms
Tender cervical node
 Node: any size22–24 29 30 34306745 (42 to 48)71 (69 to 73)40 (37 to 43)76 (74 to 77)1.6 (1.5 to 1.8)0.7 (0.7 to 0.8)2.3 (1.9 to 2.8)
 Node >1.5 cm3045181 (73 to 88)45 (40 to 50)32 (26 to 37)89 (83 to 92)1.5 (1.3 to 1.7)0.4 (0.3 to 0.6)3.6 (2.1 to 6.1)
 Node >2 cm2785740 (36 to 45)78 (74 to 81)63 (57 to 69)58 (54 to 62)1.8 (1.3 to 2.5)0.8 (0.7 to 0.9)2.4 (1.8 to 3.2)
Pharynx
 Abnormal pharynx2785742 (37 to 46)77 (72 to 80)63 (57 to 68)58 (54 to 62)1.8 (1.3 to 2.5)0.8 (0.6 to 0.9)2.3 (1.7 to 3.1)
 Pharyngeal exudate22 29 30130831 (26 to 36)81 (78 to 83)37 (32 to 42)77 (74 to 79)1.6 (1.3 to 1.9)0.9 (0.8 to 0.9)2.0 (1.5 to 2.6)
 Swollen tonsils22 34148158 (54 to 63)57 (54 to 60)39 (35 to 42)75 (72 to 78)1.3 (1.2 to 1.5)0.7 (0.7 to 0.8)1.9 (1.5 to 2.3)
Fever
 HF29 30100670 (65 to 75)32 (29 to 35)26 (23 to 30)76 (71 to 80)1.1 (1.0 to 1.1)0.9 (0.7 to 1.1)1.2 (0.9 to 1.7)
 Fever >38°C22 27 29 34278953 (50 to 56)56 (54 to 59)40 (37 to 43)68 (66 to 71)1.1 (1.1 to 1.5)0.9 (0.8 to 1.1)1.3 (1.1 to 2.2)
 Fever >38.5°C23 2457664 (57 to 70)28 (24 to 33)28 (24 to 32)64 (57 to 70)0.9 (0.8 to 1.0)1.2 (1.0 to 1.6)0.7 (0.5 to 1.1)
 HF or >38°C22 27 29 30 34379556 (54 to 60)49 (47 to 51)35 (33 to 37)70 (67 to 72)1.1 (1.1 to 1.3)0.9 (0.8 to 1.1)1.3 (1.1 to 1.9)
 Headache22–24 27173051 (48 to 55)64 (61 to 67)48 (44 to 51)67 (64 to 70)1.3 (1.1 to 1.5)0.9 (0.8 to 1.0)1.5 (1.2 to 2.2)
 Sore throat27 34204186 (83 to 88)27 (25 to 30)43 (41 to 46)75 (71 to 78)1.2 (1.1 to 1.2)0.5 (0.4 to 0.6)2.5 (2.0 to 3.2)
 Scarlatiniform rash2229714 (8 to 23)97 (93 to 98)63 (41 to 81)74 (68 to 79)4.7 (2.1 to 10.5)0.9 (0.8 to 1.0)4.8 (1.8 to 12.7)
 Petechia on the palate22–2487320 (16 to 25)88 (86 to 91)42 (34 to 51)72 (69 to 75)1.8 (1.3 to 2.5)0.9 (0.9 to 1.0)2.0 (1.3 to 2.9)
 Sudden onset23 2457632 (26 to 39)69 (65 to 74)31 (25 to 38)70 (65 to 74)1.1 (0.8 to 1.4)1.0 (0.9 to 1.1)1.1 (0.7 to 1.6)
Negative symptoms
 No cough23 24 27 29 30 34362765 (63 to 68)55 (53 to 57)43 (41 to 45)75 (73 to 77)1.5 (1.4 to 1.7)0.6 (0.6 to 0.7)2.4 (2.1 to 3.1)
 No rhinorrhoea22–24 27 30 34336571 (69 to 74)50 (48 to 52)43 (41 to 45)76 (74 to 79)1.3 (1.3 to 1.5)0.6 (0.6 to 0.8)2.2 (1.9 to 3.3)
 No abdominal pain22–2487369 (64 to 75)29 (26 to 33)30 (26 to 33)69 (64 to 74)1.0 (0.9 to 1.1)1.1 (0.8 to 1.3)1.0 (0.7 to 1.3)
 No diarrhoea23 24 27143394 (92 to 95)12 (10 to 14)43 (40 to 45)72 (65 to 79)1.1 (1.0 to 1.1)0.5 (0.3 to 0.7)2.3 (1.5 to 3.4)
 No conjunctivitis23 24576100 (NC to 100)6 (4 to 8)32 (28 to 36)100 (NC to 100)1.0 (1.0 to 1.0)NCNC
 No viral exanthema23 2457688 (83 to 92)2 (1 to 3)28 (25 to 32)22 (11 to 38)1.0 (1.0 to 1.0)8.4 (3.2 to 21.6)0.1 (0.0 to 0.3)
  • PPV and NPV should be interpreted with the prevalence of the disease in each study, available in table 1.

  • HF, history of fever; LR+, positive likelihood ratio; LR−, negative likelihood ratio; n, number of children; NC, not calculable; NPV, negative predictive value; Pop, population; PPV, positive predictive value; Se, sensitivity; Sp, specificity.